These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 16505424

  • 1. Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer.
    De Ruysscher D, Pijls-Johannesma M, Bentzen SM, Minken A, Wanders R, Lutgens L, Hochstenbag M, Boersma L, Wouters B, Lammering G, Vansteenkiste J, Lambin P.
    J Clin Oncol; 2006 Mar 01; 24(7):1057-63. PubMed ID: 16505424
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [The effect of chemo-radiotherapy on the remission and survival in patients with limited stage small cell lung cancer].
    Bozóky G, Ruby E, Góhér I, Gábor G, Mohos A, Lengyel M.
    Orv Hetil; 2005 Jul 03; 146(27):1433-8. PubMed ID: 16089103
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Thoracic radiotherapy for limited-stage small cell lung cancer: issues of timing, volumes, dose, and fractionation.
    Erridge SC, Murray N.
    Semin Oncol; 2003 Feb 03; 30(1):26-37. PubMed ID: 12635087
    [Abstract] [Full Text] [Related]

  • 7. Time factor in radiotherapy and chemotherapy for limited disease small-cell lung cancer.
    Nowara E, Suwinski R.
    Cancer Invest; 2007 Feb 03; 25(3):163-71. PubMed ID: 17530486
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Accelerated hyperfractionated radiotherapy and concomitant chemotherapy in small cell lung cancer limited-disease. Dose response, feasibility and outcome for patients treated in western Sweden, 1998-2004.
    Hallqvist A, Rylander H, Björk-Eriksson T, Nyman J.
    Acta Oncol; 2007 Feb 03; 46(7):969-74. PubMed ID: 17851846
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of thoracic radiotherapy on mortality in limited small cell lung cancer. A meta-analysis of 13 randomized trials among 2,140 patients.
    Arriagada R, Pignon JP, Ihde DC, Johnson DH, Perry MC, Souhami RL, Brodin O, Joss RA, Kies MS, Lebeau B.
    Anticancer Res; 1994 Feb 03; 14(1B):333-5. PubMed ID: 8166478
    [Abstract] [Full Text] [Related]

  • 13. Cisplatin plus etoposide chemotherapy followed by thoracic irradiation and paclitaxel plus cisplatin consolidation therapy for patients with limited stage small cell lung carcinoma.
    Kakolyris S, Agelidou A, Androulakis N, Tsaroucha E, Kouroussis Ch, Agelidou M, Karvounis N, Veslemes M, Christophylakis Ch, Argyraki A, Geroyianni A, Georgoulias V.
    Lung Cancer; 2006 Jul 03; 53(1):59-65. PubMed ID: 16716447
    [Abstract] [Full Text] [Related]

  • 14. A meta-analysis of the timing of chest irradiation in the combined modality treatment of limited-stage small cell lung cancer.
    Huncharek M, McGarry R.
    Oncologist; 2004 Jul 03; 9(6):665-72. PubMed ID: 15561810
    [Abstract] [Full Text] [Related]

  • 15. A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: a randomized trial.
    Leyvraz S, Pampallona S, Martinelli G, Ploner F, Perey L, Aversa S, Peters S, Brunsvig P, Montes A, Lange A, Yilmaz U, Rosti G, Solid Tumors Working Party of the European Group for Blood and Marrow Transplantation.
    J Natl Cancer Inst; 2008 Apr 16; 100(8):533-41. PubMed ID: 18398095
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer.
    Jiang J, Liang X, Zhou X, Huang R, Chu Z.
    Lung Cancer; 2007 Sep 16; 57(3):348-58. PubMed ID: 17485133
    [Abstract] [Full Text] [Related]

  • 19. The influence of time of radio-chemotherapy and other therapeutic factors on treatment results in patients with limited disease small cell lung cancer.
    Sas-Korczynska B, Sokolowski A, Korzeniowski S.
    Lung Cancer; 2013 Jan 16; 79(1):14-9. PubMed ID: 23153659
    [Abstract] [Full Text] [Related]

  • 20. Radiation pneumonitis following concurrent accelerated hyperfractionated radiotherapy and chemotherapy for limited-stage small-cell lung cancer: Dose-volume histogram analysis and comparison with conventional chemoradiation.
    Tsujino K, Hirota S, Kotani Y, Kado T, Yoden E, Fujii O, Soejima T, Adachi S, Takada Y.
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1100-5. PubMed ID: 16373082
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.